-
-
-
-
-
-
-
Strongbridge Biopharma plc Announces Shareholder Approval of Proposed Acquisition by Xeris Pharmaceuticals, Inc.
-
-
-
-
-
-
-
Strongbridge Biopharma plc Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue
-
-
-
-
-
-
-
Rule 2.5 Announcement: Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases
-
-
-
-
-
-
-
After-Hours Stock Movers 04/07: (AVCT) (SBBP) (CARG) Higher; (OTIC) (LNDC) (ASO) Lower (more...)
-
-
-
-
-
-
-
Strongbridge Biopharma (SBBP) Enters Agreement for Novo Nordisk (NVO) to Acquire U.S. and Canadian Rights to MACRILEN
-
-
-
-
-
-
-
Strongbridge Biopharma plc Reports Full-Year 2017 Financial Results
-
-
-
-
-
-
-
Strongbridge Biopharma plc Announces Closing of Public Offering of Ordinary Shares
-
1,155,343 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

